Bausch + Lomb and Modulight Corporation, a biomedical laser company, today announced that the FDA has approved the ML6710i photodynamic laser for equivalent use with Bausch + Lomb’s VISUDYNE® (verteporfin for injection) photodynamic therapy (PDT).

Eyenuk has received approval to market its EyeArt® AI eye screening system in the European Union for the new uses of detecting age-related macular degeneration (AMD) and glaucomatous optic nerve damage.

A collaborative team from the Terasaki Institute for Biomedical Innovation (TIBI) has developed a contact lens prototype that is specifically designed to prevent contact lens-induced dry eye (CLIDE).

HuidaGene Therapeutics has received clearance from the FDA for its investigational new drug (IND) application submitted for a planned multi-national clinical trial of HG004 to treat patients with inherited retinal dystrophies linked to RPE65 mutations.

According to a report by an international team of researchers, atropine instillation after trabeculectomy should be discouraged since it causes greater and longer lasting reduction in visual quality.

Researchers at Johns Hopkins Medicine say they have linked low blood sugar levels in people with diabetes with a molecular pathway that is turned on in oxygen-starved cells in the eye.

Regeneron Pharmaceuticals Inc. has won a patent case against Novartis AG in a U.S. court, protecting the company's drug delivery system for its eye drug Eylea.

The U.S. Food and Drug Administration has approved Oxular Limited's investigational new drug application (IND) for suprachoroidal OXU-001 for the treatment of diabetic macular edema (DME).

Researchers in Seoul, Korea, under the direction of Seong Woo Kim, MD, PhD, found that early treatment may improve the prognosis of fungal endophthalmitis caused by contaminated medical supplies.

Manufacturers, through a loophole in federal law, can use an unsafe medical device as a basis for authorization by the U.S. Food and Drug Administration (FDA) to bring new, related products to market, a Yale-led study finds.